Research Development - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.395 EUR 5.05%
Market Cap: 40.9m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gensight Biologics SA
Research & Development Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Research & Development
-€16.6m
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Research & Development
-€93m
CAGR 3-Years
11%
CAGR 5-Years
-29%
CAGR 10-Years
-14%
Nanobiotix SA
PAR:NANO
Research & Development
-€37.1m
CAGR 3-Years
-17%
CAGR 5-Years
-13%
CAGR 10-Years
-20%
Innate Pharma SA
PAR:IPH
Research & Development
-€47.1m
CAGR 3-Years
-12%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Genfit SA
NASDAQ:GNFT
Research & Development
-€35.9m
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Research & Development
-€5.9m
CAGR 3-Years
-38%
CAGR 5-Years
-33%
CAGR 10-Years
2%

See Also

What is Gensight Biologics SA's Research & Development?
Research & Development
-16.6m EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Research & Development amounts to -16.6m EUR.

What is Gensight Biologics SA's Research & Development growth rate?
Research & Development CAGR 5Y
10%

Over the last year, the Research & Development growth was 12%. The average annual Research & Development growth rates for Gensight Biologics SA have been 9% over the past three years , 10% over the past five years .

Back to Top